Accelerating Microbial Innovation with MicrobioSci

In the dynamic field of microbial biotechnology, precision, innovation, and reliability are essential to driving scientific discovery and industrial success. MicrobioSci, a dedicated division of Creative Biogene, offers a comprehensive range of microbial services and products tailored to meet the evolving needs of academic institutions, biotech companies, and pharmaceutical enterprises. With advanced capabilities and a commitment to quality, MicrobioSci serves as a trusted partner in microbial research and development.

One of the key services provided by MicrobioSci is Recombinant Vaccine Production. In response to the growing global demand for safer and more effective vaccines, the platform offers end-to-end solutions for the development of recombinant vaccines using various microbial expression systems. This includes gene synthesis, vector construction, expression optimization, protein purification, and scale-up production. The service is designed to accelerate time-to-market while ensuring high yield, purity, and biological activity of the recombinant antigens.

Alongside vaccine development, maintaining consistency and safety in microbial processes is critical. That is why MicrobioSci has developed a rigorous Fermentation Quality Control System. This system monitors critical process parameters such as pH, temperature, dissolved oxygen, and biomass in real time, ensuring reproducibility across fermentation batches. It enables researchers and manufacturers to achieve optimal fermentation performance while meeting regulatory requirements.

To support large-scale and reproducible production, MicrobioSci offers high-quality E. coli Cell Banking services. These services provide clients with well-characterized, genetically stable E. coli strains preserved under stringent conditions. The availability of standardized E. coli cell banks plays a crucial role in reducing variability in protein expression and enhancing the scalability of production processes.

Another unique feature of MicrobioSci’s offerings lies in its supply of specialized enzymes for advanced research. The Trichoderma harzianum Lysing Enzymes, for example, are widely used for degrading fungal cell walls, isolating protoplasts, and supporting a variety of plant pathology and molecular biology studies. These enzymes are carefully produced and quality-tested to ensure superior activity and reliability in experimental applications.

For researchers working with yeast, MicrobioSci provides a professional Yeast Genome Editing Service. Utilizing state-of-the-art genome engineering technologies such as CRISPR/Cas9, this service allows for precise modification of the yeast genome, including gene knockout, gene integration, and promoter replacement. Whether used in synthetic biology, metabolic engineering, or industrial fermentation, this genome editing service supports efficient strain optimization and functional analysis.

In addition, MicrobioSci has become a leading provider of resources for Bacillus research. The platform offers a diverse collection of Bacillus subtilis 168 Knockout Strains, which are valuable tools for functional genomics, metabolic pathway analysis, and drug target identification. These strains are developed using precise gene editing techniques and are fully validated for downstream applications.

Furthermore, MicrobioSci offers custom Bacillus subtilis Strain Development services. Researchers can request strain modifications for improved enzyme production, stress tolerance, biosynthetic capabilities, or other desired traits. Each project is carried out with strict quality control and technical support to ensure the engineered strains meet specific research or production goals.

With a focus on innovation and scientific excellence, MicrobioSci by Creative Biogene continues to provide integrated solutions that advance microbial research and industrial biotechnology. From recombinant vaccine production and quality-controlled fermentation systems to specialized microbial strains and genome editing tools, MicrobioSci is committed to supporting progress across multiple sectors of life science.

High-quality enzyme products. Well-defined strains can be also provided for our clients to manufacture fermented products in a cost-effective way.
Creative Biogene Launches Comprehensive Recombinant Vaccine Production Services to Accelerate Global Vaccine Development

Creative Biogene, a leading biotechnology company specializing in life science research and pharmaceutical development, has officially launched its comprehensive Recombinant Vaccine Production Services. These services are designed to support vaccine developers, pharmaceutical companies, and research institutions by providing end-to-end solutions—from antigen design to large-scale manufacturing.

Recombinant vaccines are created using advanced genetic engineering techniques that introduce DNA encoding specific antigens into expression systems to produce immunogenic proteins. Compared to traditional vaccines, recombinant vaccines offer greater safety, stability, and adaptability for a wide range of infectious and non-infectious diseases.

Key Service Highlights:

Diverse Expression Systems:
Creative Biogene offers a broad selection of expression systems, including E. coli, yeast, mammalian cells, and insect cells, to meet the production needs of various vaccine antigens.

Advanced Purification Processes:
The company employs cutting-edge purification technologies to ensure high purity and bioactivity of antigen proteins, meeting the stringent standards of preclinical and clinical development.

Scalable Manufacturing:
With cGMP-compliant production facilities, Creative Biogene supports manufacturing at all scales—from pilot runs to large-scale production—catering to every stage of the vaccine lifecycle.

Custom-Tailored Solutions:
Personalized project plans are available based on client requirements, accelerating the journey from vaccine discovery to market readiness.

Creative Biogene’s recombinant vaccine services have already been successfully applied in numerous vaccine programs targeting viral diseases, bacterial infections, and even cancer. By combining innovative technology with expert scientific support, the company aims to drive progress in global vaccine innovation.

About Creative Biogene:
Creative Biogene is a trusted provider of biotechnology services for life sciences and biopharmaceutical industries. With strong technical platforms and a team of experienced scientists, the company offers high-quality solutions in gene synthesis, protein expression, cell line development, and vaccine production.For more information about these services, visit MicrobioSci at Creative Biogene.